sample	study	diagnosis	group	age	sex	bmi	country	region	pcr_primers	platform	disease_name	title	disease_name_ab	host_body_mass_index
DRR111002	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111003	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111004	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111005	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111006	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111007	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111008	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111010	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111011	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111012	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111013	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111014	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111015	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111016	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111017	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111018	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111019	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111020	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111021	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111022	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111023	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111024	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111025	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111026	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111027	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111028	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111029	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111031	PRJDB6472	C	0.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111032	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111033	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111034	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111035	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111036	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111037	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111038	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111039	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111040	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111041	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111042	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111043	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111044	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111045	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111046	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111047	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111048	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111049	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111050	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111051	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111052	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111053	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111054	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR111055	PRJDB6472	CAD	1.0				Japan	V3-V4?	f(CCTACGGGAGGCTGCAG), r(GACTACAGGGGTATCTAATCC)	ILLUMINA	coronary artery disease	Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis	CAD	
DRR151663	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151664	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151665	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151666	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151667	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151668	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151669	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151670	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151671	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151672	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151673	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151674	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151675	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151676	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151677	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151678	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151679	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151680	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151681	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151682	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151683	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151684	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151685	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151686	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151687	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151688	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151689	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151690	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151691	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151692	PRJDB7456	C	0.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151693	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151694	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151695	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151696	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151697	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151698	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151699	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151700	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151701	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151702	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151703	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151704	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151705	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151706	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151707	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151708	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151709	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151710	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151711	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151712	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151713	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151714	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151715	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151716	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151717	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151718	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151719	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151720	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151721	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151722	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151723	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151724	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
DRR151725	PRJDB7456	CAD	1.0				Japan	V3-V4?	f(CTACGGGGGGCAGCAG) r(GGACTACNNGGGTATCTAAT)	Illumina MiSeq	coronary artery disease	Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease	CAD	
